$6.32
-0.22-3.36%
At Close: -
$6.30
-0.02-0.32%
After Hours: 7:55 PM EDT
15 minutes delayed
ImmunityBio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmunityBio using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IBRX | ImmunityBio | -$0.32 | — | — | — | $41.00K | — | — | — | 08/06/2024 | Get Alert |
IBRX | ImmunityBio | -$0.27 | -$0.16 | -$0.20 | -25.00% | $360.00K | $20.00K | $40.00K | 100.00% | 05/09/2024 | Get Alert |
IBRX | ImmunityBio | -$0.27 | -$0.18 | -$0.38 | -111.11% | $73.00K | $20.00K | $139.00K | 595.00% | 03/19/2024 | Get Alert |
IBRX | ImmunityBio | -$0.28 | -$0.27 | -$0.19 | 29.63% | $118.00K | $30.00K | $82.00K | 173.33% | 11/09/2023 | Get Alert |
IBRX | ImmunityBio | -$0.24 | -$0.23 | -$0.32 | -39.13% | $35.00K | — | $41.00K | — | 08/08/2023 | Get Alert |
IBRX | ImmunityBio | -$0.26 | $0.00 | -$0.27 | — | $14.00K | $360.00K | $360.00K | 0.00% | 05/11/2023 | Get Alert |
IBRX | ImmunityBio | -$0.23 | -$0.22 | -$0.27 | -22.73% | $390.00K | $30.00K | $73.00K | 143.33% | 03/01/2023 | Get Alert |
IBRX | ImmunityBio | -$0.22 | — | -$0.22 | — | $66.00K | — | $118.00K | — | 11/09/2022 | Get Alert |
IBRX | ImmunityBio | -$0.23 | — | -$0.24 | — | $339.00K | — | $35.00K | — | 08/08/2022 | Get Alert |
IBRX | ImmunityBio | -$0.21 | — | -$0.26 | — | $139.00K | — | $14.00K | — | 05/10/2022 | Get Alert |
IBRX | ImmunityBio | -$0.18 | — | -$0.23 | — | -$147.00K | — | $390.00K | — | 03/02/2022 | Get Alert |
IBRX | ImmunityBio | -$0.17 | — | -$0.22 | — | $151.00K | — | $66.00K | — | 11/12/2021 | Get Alert |
IBRX | ImmunityBio | — | — | -$0.23 | — | — | — | $339.00K | — | 08/12/2021 | Get Alert |
IBRX | ImmunityBio | — | — | -$0.21 | — | — | — | $139.00K | — | 05/14/2021 | Get Alert |
IBRX | ImmunityBio | — | — | -$0.89 | — | — | — | $111.00K | — | 03/04/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.20 | $-0.16 | -25.0 % |
Dec 2023 | 2024-03-19 | $-0.38 | $-0.18 | -111.1 % |
Sep 2023 | 2023-11-09 | $-0.19 | $-0.27 | 29.6 % |
Jun 2023 | 2023-08-08 | $-0.32 | $-0.23 | -39.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $40.00K | $20.00K | 100.0 % |
Dec 2023 | 2024-03-19 | $139.00K | $20.00K | 595.0 % |
Sep 2023 | 2023-11-09 | $82.00K | $30.00K | 173.3 % |
Mar 2023 | 2023-05-11 | $360.00K | $360.00K | 0.00 % |
ImmunityBio (IBRX) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.20, which missed the estimate of $-0.16.
The Actual Revenue was $40K, which beat the estimate of $20K.
Browse earnings estimates, EPS, and revenue on all stocks.